A novel activating JAK1 mutation in chronic eosinophilic leukemia.
Shomali W, Damnernsawad A, Theparee T, Sampson D, Morrow Q, Yang F, Fernandez-Pol S, Press R, Zehnder J, Tyner JW, Gotlib J.
Shomali W, et al.
Blood Adv. 2021 Sep 28;5(18):3581-3586. doi: 10.1182/bloodadvances.2021004237.
Blood Adv. 2021.
PMID: 34496019
Free PMC article.
The use of myeloid next-generation sequencing (NGS) panels has led to the detection of several mutations in patients previously diagnosed with HEUS, reassigning some patients to the category of HEN, specifically the World Health Organization category of chronic eosinoph …
The use of myeloid next-generation sequencing (NGS) panels has led to the detection of several mutations in patients previously diagnosed wi …